HCS Pharma @ Drug Discovery 2018

Our study director Elodie will attend Drug Discovery 2018 – THE ELRIG‘s flagship conference – which will take place in London next week! We are looking forward to presenting our poster about neurotoxicity testing. Don’t hesitate to visit Elodie there, she will answer to your questions about our results, and/or our different services! You want to book a meeting? Contact us!

In this study, sensitivity of iPSC-derived neuronal cells to 32 compounds was compared to the sensitivity of differentiated SH-SY5Y cells. Two types of iPSC-derived cells were tested: central nervous system cells (CNS.4U® cells) and peripheral nervous system cells (PERI.4U® cells) from Ncardia. Toxic effects were then measured using high content imaging:

You can have access to the poster by following this linkas of now (with the possibility to request a high quality version).

As we are involved in some very interesting projects, we have the chance to work with amazing specialists in many field. All these people help us to make the BIOMIMESYS® technology better, easier to use Read more…

Dear all, We hope this email finds you, your family and colleagues well! We are available to discuss with you:– about your needs in high content screening/analysis services. We would be happy to organise videoconferences Read more…